Regenxbio (RGNX) Change in Receivables (2014 - 2025)

Regenxbio's Change in Receivables history runs 12 years deep, the most recent figure standing at $561000.0 for Q4 2025.

• In Q4 2025, Change in Receivables rose 106.9% year-over-year to $561000.0; the TTM figure through Dec 2025 stood at $7.7 million (up 178.92% YoY), while the FY2025 annual figure was $7.7 million, up 178.92% from the prior year.
• Change in Receivables for Q4 2025 stood at $561000.0, down from $6.3 million in the prior quarter.
• The five-year high for Change in Receivables was $10.7 million in Q2 2022, with the low at -$22.0 million in Q4 2021.
• The 5-year median for Change in Receivables is -$505500.0 (2025), against an average of -$1.2 million.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables slumped 251.61% in 2022, then jumped 788.73% in 2025.
• Regenxbio's Change in Receivables stood at -$22.0 million in 2021, then surged by 77.99% to -$4.8 million in 2022, then surged by 30.45% to -$3.4 million in 2023, then sank by 141.41% to -$8.1 million in 2024, then surged by 106.9% to $561000.0 in 2025.
• Business Quant data shows RGNX's Change in Receivables at $561000.0 in Q4 2025, $6.3 million in Q3 2025, and $2.4 million in Q2 2025.